Emerging Tech Startups - Singapore Landscape Report
Funding Activities by Funding Round: 2022
More intermediate rounds were raised in 2022 versus 2021; the average seed round size fell for all
verticals except for the Health and Biomedical Sciences.
Advanced Manufacturing
A+
Agrifood
Public market volatility is creating a ripple effect, which has
introduced uncertainty into the private market
• We noticed more companies raising immediate funding rounds. This
could be an attempt to extend their runway and minimise the impact
on valuations until the macro-economic environment improves
2022
2021
Seed+/Pre-A
15
7
A+
5
2
A
Seed+/
Pre-A
Seed
°
10
●Additive Manufacturing
●Space Tech
Round Size (US$ M)
Automation
● Advanced Matertials
A
Seed+/
Pre-A
Seed
Sustainability
A
Seed+/
Pre-A
The average seed round size in 2022 varied considerably across the
four verticals compared to 2021.
US$' M
Seed
15
20
10
15
20 100
Advanced
Manufacturing
2022
0.6
1.5
2021
Round Size (US$ M)
● Sensors and Electronics
• Agritech
● Alternative Proteins
Food Tech
Agrifood
1.5
2.3
Sustainability
1.2
2.6
Health and Biomedical Sciences
Health and
5.2
2.1
Biomedical
A+
A
Seed+/
Pre-A
Seed
Next Gen Foods raised a US$100M series A round, dominating the
landscape in 2022, across all four verticals.
The announcement of 2 potential early public exits in the Health and
Biomedical Sciences vertical has created a great deal of excitement
in the local ecosystem:
AUM Biosciences (2018) is pending a SPAC on NASDAQ through
Mountain Crest Acquisition Corp
°
5
10
15
20
0
5
10
15
20
●Decarbonisation
Round Size (US$ M)
●Resource Optimisation
Round Size (US$ M)
Sustainable Materials
◆ Medical Device
● Diagnostics
• Platform Tech
● Therapeutics
•
CytoMed Therapeutics (2018) is preparing for a NASDAQ listing
12
* Funding round names and amounts are based on press releases, social media announcements, or entries on venture capital databasesView entire presentation